PodParley PodParley
PodParley
FDA D.I.S.C.O. Burst Edition: FDA approval of Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy for metastatic non-small cell lung cancer episode artwork

EPISODE · Dec 5, 2022 · 3 MIN

FDA D.I.S.C.O. Burst Edition: FDA approval of Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy for metastatic non-small cell lung cancer

from FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) · host U.S. Food and Drug Administration, Center for Drug Evaluation and Research

Listen to a soundcast of the November 10th 2022 FDA approval of Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy for metastatic non-small cell lung cancer

Episode metadata supplied by the publisher feed · Published Dec 5, 2022

Embed this episode

Ready to play

FDA D.I.S.C.O. Burst Edition: FDA approval of Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy for metastatic non-small cell lung cancer

0:00 3:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

輕鬆講講故丨粵語丨暴走的陳老C丨廣東話 暴走的陳老C 《輕鬆講講古》

Frequently Asked Questions

How long is this episode of FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)?

This episode is 3 minutes long.

When was this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode published?

This episode was published on December 5, 2022.

Can I download this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!